Infectious Diseases Update: Using Guidelines to Optimize Treatment
Track:
Education Sessions (CE)
Program Code: 232-L01
Date: Wednesday, December 11, 2013
Time: 2:00 PM to 4:00 PM EST
Location:
Valencia W415 D, Level 4
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Kevin Garey, PharmD, MS, Associate Professor, University of Houston
Kevin Garey, PharmD, MS is an Associate Professor at the University of Houston College of Pharmacy and Chair of the Department of Clinical Sciences and Administration. He received a Bachelor of Science in Pharmacy degree from Dalhousie University in Halifax, Nova Scotia, Canada, a Doctor of Pharmacy from SUNY Buffalo in Buffalo, NY, and a Masters of Science in Biometry from the University of Texas School of Public Health in Houston, Texas. Postdoctoral training includes a pharmacy practice residency in Cooperstown, NY and infectious disease specialty residency and fellowship training in Chicago, IL. Dr. Garey's research interests involve infectious disease epidemiology and pharmacotherapy in patients with post-surgical infections including sternal wound infections, candidemia, and Clostridium difficile infection.
Michael Rybak
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Kevin Garey, PharmD, MS, Associate Professor, University of Houston
Kevin Garey, PharmD, MS is an Associate Professor at the University of Houston College of Pharmacy and Chair of the Department of Clinical Sciences and Administration. He received a Bachelor of Science in Pharmacy degree from Dalhousie University in Halifax, Nova Scotia, Canada, a Doctor of Pharmacy from SUNY Buffalo in Buffalo, NY, and a Masters of Science in Biometry from the University of Texas School of Public Health in Houston, Texas. Postdoctoral training includes a pharmacy practice residency in Cooperstown, NY and infectious disease specialty residency and fellowship training in Chicago, IL. Dr. Garey's research interests involve infectious disease epidemiology and pharmacotherapy in patients with post-surgical infections including sternal wound infections, candidemia, and Clostridium difficile infection.
Apply data from the updated vancomycin monitoring guidelines to the care and treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.
Evaluate appropriate treatment regimens for candidemia based on the recently published candidiasis guidelines.
Given a specific case of a patient with Clostridium difficile Infection, identify methods to decrease the likelihood of Clostridium difficile Infection recurrence.